Literature DB >> 23532706

Brain effect of insulin and clonazepam in diabetic rats under depressive-like behavior.

Carlos Alberto Yasin Wayhs1, Caroline Paula Mescka, Camila Simioni Vanzin, Graziela Schmitt Ribas, Gilian Guerreiro, Maurício Schüler Nin, Vanusa Manfredini, Helena Maria Tannhauser Barros, Carmen Regla Vargas.   

Abstract

Diabetes mellitus is characterized by hyperglycemia resulting from defects on insulin secretion, insulin action, or both. It has recently become clear that the central nervous system is not spared from the deleterious effects of diabetes, since diabetic encephalopathy was recognized as a complication of this heterogeneous metabolic disorder. There is a well recognized association between depression and diabetes, once prevalence of depression in diabetic patients is higher than in general population, and clonazepam is being used to treat this complication. Oxidative stress is widely accepted as playing a key mediatory role in the development and progression of diabetes and its complications. In this work we analyzed DNA damage by comet assay and lipid damage in prefrontal cortex, hippocampus and striatum of streptozotocin-induced diabetic rats submitted to the forced swimming test. It was verified that the diabetic group presented DNA and lipid damage in the brain areas evaluated, when compared to the control groups. Additionally, a significant reduction of the DNA and lipid damage in animals treated with insulin and/or clonazepam was observed. These data suggest that the association of these two drugs could protect against DNA and lipid damage in diabetic rats submitted to the forced swimming test, an animal model of depression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23532706     DOI: 10.1007/s11011-013-9397-z

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  48 in total

1.  Recommendations for conducting the in vivo alkaline Comet assay. 4th International Comet Assay Workshop.

Authors:  A Hartmann; E Agurell; C Beevers; S Brendler-Schwaab; B Burlinson; P Clay; A Collins; A Smith; G Speit; V Thybaud; R R Tice
Journal:  Mutagenesis       Date:  2003-01       Impact factor: 3.000

Review 2.  Insulin in the brain: a hormonal regulator of energy balance.

Authors:  M W Schwartz; D P Figlewicz; D G Baskin; S C Woods; D Porte
Journal:  Endocr Rev       Date:  1992-08       Impact factor: 19.871

3.  Release of immunoreactive insulin from rat brain synaptosomes under depolarizing conditions.

Authors:  L T Wei; H Matsumoto; D E Rhoads
Journal:  J Neurochem       Date:  1990-05       Impact factor: 5.372

Review 4.  Role of insulin and insulin receptor in learning and memory.

Authors:  W Q Zhao; D L Alkon
Journal:  Mol Cell Endocrinol       Date:  2001-05-25       Impact factor: 4.102

5.  Interaction of electrophilic lipid oxidation products with mitochondria in endothelial cells and formation of reactive oxygen species.

Authors:  Aimee Landar; Jaroslaw W Zmijewski; Dale A Dickinson; Claire Le Goffe; Michelle S Johnson; Ginger L Milne; Giuseppe Zanoni; Giovanni Vidari; Jason D Morrow; Victor M Darley-Usmar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-12-30       Impact factor: 4.733

6.  Differential effects of diazepam on anxiety in streptozotocin induced diabetic and non-diabetic rats.

Authors:  M Ramanathan; A K Jaiswal; S K Bhattacharya
Journal:  Psychopharmacology (Berl)       Date:  1998-02       Impact factor: 4.530

Review 7.  The impact of diabetes on cognition: what can be learned from rodent models?

Authors:  Geert Jan Biessels; Willem Hendrik Gispen
Journal:  Neurobiol Aging       Date:  2005-10-11       Impact factor: 4.673

8.  Depression, anxiety and glucose metabolism in the general dutch population: the new Hoorn study.

Authors:  Vanessa Bouwman; Marcel C Adriaanse; Esther van 't Riet; Frank J Snoek; Jacqueline M Dekker; Giel Nijpels
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

9.  Cognitive profiles of children with insulin-dependent diabetes.

Authors:  C S Holmes; L C Richman
Journal:  J Dev Behav Pediatr       Date:  1985-12       Impact factor: 2.225

10.  A review of exenatide as adjunctive therapy in patients with type 2 diabetes.

Authors:  Gisela I Robles; Devada Singh-Franco
Journal:  Drug Des Devel Ther       Date:  2009-09-21       Impact factor: 4.162

View more
  6 in total

1.  Effect of streptozotocin-induced diabetes on performance on a progressive ratio schedule.

Authors:  Lourdes Valencia-Torres; C M Bradshaw; Arturo Bouzas; Enrique Hong; Vladimir Orduña
Journal:  Psychopharmacology (Berl)       Date:  2014-01-09       Impact factor: 4.530

2.  Zeaxanthin improved diabetes-induced anxiety and depression through inhibiting inflammation in hippocampus.

Authors:  Xiaoyan Zhou; Tian Gan; Gaoxia Fang; Shangshang Wang; Yizhen Mao; Changjiang Ying
Journal:  Metab Brain Dis       Date:  2017-12-30       Impact factor: 3.584

3.  Indoleamine-2,3-Dioxygenase/Kynurenine Pathway as a Potential Pharmacological Target to Treat Depression Associated with Diabetes.

Authors:  Isabella Caroline da Silva Dias; Bruno Carabelli; Daniela Kaori Ishii; Helen de Morais; Milene Cristina de Carvalho; Luiz E Rizzo de Souza; Silvio M Zanata; Marcus Lira Brandão; Thiago Mattar Cunha; Anete Curte Ferraz; Joice Maria Cunha; Janaina Menezes Zanoveli
Journal:  Mol Neurobiol       Date:  2015-12-15       Impact factor: 5.590

4.  Metabolic Changes Associated with a Rat Model of Diabetic Depression Detected by Ex Vivo 1H Nuclear Magnetic Resonance Spectroscopy in the Prefrontal Cortex, Hippocampus, and Hypothalamus.

Authors:  Kun Liu; Liangcai Zhao; Wen Xu; Qiuting Lin; Yongjin Zhou; Xiaoyan Huang; Xinjian Ye; Jiawei He; Guanghui Bai; Zhihan Yan; Hongchang Gao
Journal:  Neural Plast       Date:  2018-04-08       Impact factor: 3.599

5.  Antidepressant, Anxiolytic and Neuroprotective Activities of Two Zinc Compounds in Diabetic Rats.

Authors:  Christiane Leite Cavalcanti; Maria Conceição Rodrigues Gonçalves; Adriano Francisco Alves; Emmanuel Veríssimo de Araújo; Jader Luciano P Carvalho; Priscilla Paulo Lins; Raquel Coutinho Alves; Naís Lira Soares; Liana Clebia Morais Pordeus; Jailane Souza Aquino
Journal:  Front Neurosci       Date:  2020-01-21       Impact factor: 4.677

6.  Ginseng Extracts, GS-KG9 and GS-E3D, Prevent Blood-Brain Barrier Disruption and Thereby Inhibit Apoptotic Cell Death of Hippocampal Neurons in Streptozotocin-Induced Diabetic Rats.

Authors:  Jee Youn Lee; Chan Sol Park; Hae Young Choi; Tae Young Yune
Journal:  Nutrients       Date:  2020-08-09       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.